Methods for assessing uncertainty in fundamental assumptions and associated models for cancer risk assessment

Risk Analysis

Volumn 28, Issue 5, 2008, Pages 1289-1308

  Small, Mitchell J ^a  

^a CARNEGIE MELLON UNIVERSITY   (United States)

Author keywords

Bayesian belief network; Cancer risk assessment; Distributional method; Expert judgment; Genotoxicity; Mode of action; Uncertainty analysis; Weight of evidence

Indexed keywords

BAYESIAN NETWORKS; DAMAGE DETECTION; DECISION THEORY; DISEASES; ESTIMATION; MAXIMUM LIKELIHOOD ESTIMATION; METABOLITES; NAPHTHALENE; RISK ASSESSMENT; RISK PERCEPTION;

CANCER RISK ASSESSMENTS; DISTRIBUTIONAL METHOD; EXPERT JUDGMENT; GENOTOXICITIES; MODE OF ACTION; WEIGHT OF EVIDENCES;

UNCERTAINTY ANALYSIS;

BIOASSAY; CANCER; DOSE-RESPONSE RELATIONSHIP; GENOTOXICITY; HEALTH RISK; MODELING; NUMERICAL METHOD; RISK ASSESSMENT; SOFTWARE; UNCERTAINTY ANALYSIS;

BAYES THEOREM; CANCER RISK; DNA DAMAGE; GENOTOXICITY; MEDICAL INFORMATION; REVIEW; RISK ASSESSMENT;

EID: 52749099064     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/j.1539-6924.2008.01134.x     Document Type: Review

References (90)

1. Cohen, J.T. (2007) A White Paper Written To Address EPA IRIS Issue Topic 1: A comprehensive look at uncertainty analysis of carcinogenic risk assessments: Taking a broad view. Report prepared for U.S. Environmental Protection Agency by the Institute for Clinical Research and Health Policy Studies, Tufts-New England Medical Center, Report T-NEMC #063, Boston, MA.
2. Holland, C. D., & Sielken, R. L. Jr. 1993). Quantitative Cancer Modeling and Risk Assessment. (Chapter 7). Englewood Cliffs, NJ : Prentice Hall.
3. Evans, J. S., Graham, J. D., Gray, G. M., & Sielken, R. L. Jr. 1994). A distributional approach to characterizing low-dose cancer risk. Risk Analysis, 14 (1 25 34.
4. Evans, J. S., Graham, J. D., Gray, G. M., & Sielken, R. L. Jr. 1995). A distributional approach to characterizing low-dose cancer risk. In S. Olin, W. Farland, C. Park, L. Rhomberg, R. Scheuplein, T. Starr, & J. Wilson (Eds. Low-Dose Extrapolation of Cancer Risks (pp. 253 274). Washington, DC : ILSI Press.
5. Sielken, R. L. Jr. 1993). Evaluation of chloroform risk to humans. The Toxicology Forum, 1993 Annual Winter Meeting, February 15-17, 1993, The Capitol Hilton, Washington, DC.
6. Evans, J. S., Gray, G. M., Sielken, R. L., Jr., Smith, A. E., Valdez-Flores, C., & Graham, J. D. (1994). Use of probabilistic expert judgment in distributional analysis of carcinogenic potency. Regulatory Toxicology and Pharmacology, 20 (1 15 36.
7. Sielken, R. L., Jr., & Valdez-Flores, C. (1999). Probabilistic risk assessment's use of trees and distributions to reflect uncertainty and variability and to overcome the limitations of default assumptions. Special Issue of Environmental International on Modeling and Simulation, 25, 755 772.
8. Sielken, R. L. Jr. 1990). A weight-of-evidence approach to quantitative cancer risk assessment: Information analysis. In G. Schettler, D. Schmähl, & T. Klenner (Eds. Risk Assessment in Chemical Carcinogenesis. New York : Springer-Verlag. Proceedings of the Satellite Symposium on Risk Assessment in Chemical Carcinogenesis, Heidelberg, Germany August 24-25, 1990.
9. Sielken, R. L., Jr., Bretzlaff, R. S., & Stevenson, D. E. (1995). Challenges to default assumptions stimulate comprehensive realism as a new tier in quantitative cancer risk assessment. Regulatory Toxicology and Pharmacology, 21, 270 280.
10. Sielken, R. L., Jr., & Valdez-Flores, C. (1996). Comprehensive realism's weight-of-evidence based distributional dose-response characterization. Special Issue of the Human and Ecological Risk Assessment on Theoretical, Toxicological and Biostatistical Foundations for Deriving Probability Distribution Functions for Reference Doses and Benchmark Doses with Application to Carcinogens and Noncarcinogens, 2 (1 175 193.
11. Boyce, C. P. (1998). Comparison of approaches for developing distributions for carcinogenic slope factors. Human and Ecological Risk Assessment, 4 (2 527 577.
12. Moschandreas, D. J., & Karuchit, S. (2002). Scenario-model-parameter - A new method of cumulative risk uncertainty analysis. Environment International, 28 (4 247 261.
13. Zeise, L., Hattis, D., Andersen, M., Bailer, A. J., Bayard, S., Chen, C., Clewell, H., Conolly, R., Crump, K., Dunson, D., Finkel, A., Haber, L., Jarabek, A. M., Kodell, R., Krewski, D., Thomas, D., Thorslund, T., & Wassell, J. (2002). Improving risk assessment: Research opportunities in dose response modeling to improve risk assessment. Human and Ecological Risk Assessment, 8 (6 1421 1444.
14. Humphreys, S. H., Carrington, C., & Bolger, M. (2001). A quantitative risk assessment for fumonisins B1 and B2 in US corn. Food Additives and Contaminants, 18 (3 211 220.
15. Rai, S. N., Bartlett, S., Krewski, D., & Paterson, J. (2002). The use of probabilistic risk assessment in establishing drinking water quality objectives. Human and Ecological Risk Assessment, 8 (3 493 509.
16. Kirman, C. R., Sweeney, L. M., Teta, M. J., Sielken, R. L., Valdez-Flores, C., Albertini, R. J., & Gargas, M. L. (2004). Addressing nonlinearity in the exposure-response relationship for a genotoxic carcinogen: Cancer potency estimates for ethylene oxide. Risk Analysis, 24 (5 1165 1183.
17. Starr, T. B., Matanoski, G., Anders, M. W., & Andersen, M. E. (2006). Workshop overview: Reassessment of the cancer risk of dichloromethane in humans. Toxicological Sciences, 91 (1 20 28.
18. David, R. M., Clewell, H. J., Gentry, P. R., Covington, T. R., Morgott, D. A., & Marino, D. J. (2006). Revised assessment of cancer risk to dichloromethane II. Application of probabilistic methods to cancer risk determinations. Regulatory Toxicology Pharmacology, 45 (1 55 65.
19. Crump, K. S. (1994). Risk of benzene-induced leukemia: A sensitivity analysis of the Pliofilm cohort with additional follow-up and new exposure estimates. Journal Toxicology and Environmental Health, 42, 219 242.
20. Cox, L. A. (2006). Quantifying potential health impacts of cadmium in cigarettes on smoker risk of lung cancer: A portfolio-of-mechanisms approach. Risk Analysis, 26 (6 1581 1599.
21. Crouch, E. A. C., Lester, R. R., Lash, T. L., Armstrong, S. R., & Green, L. C. (1995). Report to the Commission on Risk Assessment: Health Risk Assessments Prepared per the Risk Assessment Reforms Under Consideration in the U.S. Congress. Cambridge Environmental Inc., Available at http://oaspub.epa.gov/ eims/eimsapi.dispdetail?deid=55006. Also available at http://www.riskworld.com/ nreports/1996/risk_rpt/pdf/cambrdg.pdf. See especially Appendix B: Obtaining distributions for carcinogenic potencies derived from studies on laboratory animals.
22. Piegorsch, W. W., & West, R. W. (2005). Benchmark analysis: Shopping with proper confidence. Risk Analysis, 25 (4 913 920.
23. Piegorsch, W. W., West, R. W., Pan, W., & Kodell, R. L. (2005). Low dose risk estimation via simultaneous statistical inferences. Applied Statistics, 54 (1 245 258.
24. Hasselblad, V., & Jarabek, A. M. (1996). Dose-response analysis of toxic chemicals. In D. A. Berry & D. K. Stangl (Eds. Bayesian Biostatistics (pp. 235 259). New York : Marcel Dekker.
25. Chu, H. -M., & Kuo, L. (1997). Sampling based approach for one-hit and multi-hit models in quantal bioassay. Statistics and Computing, 7 (3 183 192.
26. Dunson, D. B. (2001). Modeling changes in tumor burden. Journal of Agricultural, Biological and Environmental Statistics, 6 (1 38 48.
27. Dunson, D. B., & Dinse, G. E. (2001). Bayesian incidence analysis of animal tumorigenicity. Journal of the Royal Statistical Society: Series C (Applied Statistics), 50 (2 125 141.
28. U.S. EPA Science Advisory Board 1997). An SAB Report: Guidelines for Cancer Risk Assessment. EPA-SAB_EHC-97-010, Washington, DC. Available at http://www.epa.gov/sab/pdf/ehc9710.pdf.
29. Guidelines for Carcinogen Risk Assessment. U.S. EPA. (2005). EPA/630/P-03/001F, Washington, DC. Available at http://www.epa.gov/iris/ cancer032505-final.pdf.
30. Morgan, M. G., Henrion, M., Morris, S. C., & Amaral, D. A. L. (1985). Uncertainty in risk assessment. Environmental Science & Technology, 19 (8 662 667.
31. Stiber, N. A., Pantazidou, M., & Small, M. J. (1999). Expert system methodology for evaluating reductive dechlorination at TCE sites. Environmental Science & Technology, 33 (17 3012 3020.
32. Morgan, M. G., Pitelka, L. F., & Shevliakova, E. (2001). Elicitation of expert judgments of climate change impacts on forest ecosystems. Climatic Change, 49, 279 307.
33. Arnell, N. W., Tompkins, E. L., & Adger, W. N. (2005). Eliciting information from experts on the likelihood of rapid climate change. Risk Analysis, 25 (6 1419 1431.
34. Gill, J., & Walker, L. D. (2005). Elicited priors for Bayesian model specifications in political science research. Journal of Politics, 67 (3 841 872.
35. Hawkins, N. C., & Graham, J. D. (1988). Expert scientific judgment and cancer risk assessment: A pilot study of pharmacokinetic data. Risk Analysis, 8 (4 615 625.
36. Casman, E. A., & Morgan, M. G. (2005). Use of expert judgment to bound lung cancer risks. Environmental Science & Technology, 39 (16 5911 5920.
37. Grist, E. P. M., O'Hagan, A., Crane, M., Sorokin, N., Sims, I., & Whitehouse, P. (2006). Bayesian and time-independent species sensitivity distributions for risk assessment of chemicals. Environmental Science & Technology, 40 (1 395 401.
38. Cooke, R. M., Wilson, A. M., Tuomisto, J. T., Morales, O., Tainio, M., & Evans, J. S. (2007). A probabilistic characterization of the relationship between fine particulate matter and mortality: Elicitation of European experts. Environmental Science & Technology, 41 (18 6598 6605.
39. Kandlikar, M., Ramachandran, G., Maynard, A., Murdockand, B., & Toscano, W. (2007). Health risk assessment for nanoparticles: A case for using expert judgment. Journal of Nanoparticle Research, 9 (1 137 156.
40. Chaloner, K. M. (1996). The elicitation of prior distributions. In D. A. Berry & D. K. Stangl (Eds. Bayesian Biostatistics (pp. 141 156). New York : Marcel Dekker.
41. Kadane, J. B., & Wolfson, L. J. (1998). Experiences in elicitation. Statistician, 47 (1 3 19.
42. Garthwaite, P. H., Kadane, J. B., & O'Hagan, A. (2005). Statistical methods for eliciting probability distributions. Journal of the American Statistical Association, 100 (470 680 700.
43. Fayerweather, W. E., Collins, J. J., Schnatter, A. R., Hearn, F. T., Menning, R. A., & Reyner, D. P. (1999). Quantifying uncertainty in a risk assessment using human data. Risk Analysis, 19 (6 1077 1090.
44. Conolly, R. B., Kimbell, J. S., Janszen, D., Schlosser, P. M., Kalisak, D., Preston, J., & Miller, F. J. (2003). Biologically motivated computational modeling of formaldehyde carcinogenicity in the F344 rat. Toxicological Sciences, 75, 432 447.
45. Conolly, R. B., Kimbell, J. S., Janszen, D., Schlosser, P. M., Kalisak, D., Preston, J., & Miller, F. J. (2004). Human respiratory tract cancer risks of inhaled formaldehyde: Dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset. Toxicological Sciences, 82 (1 279 296.
46. Hester, S. D., Barry, W. T., Zou, F., & Wolf, D. C. (2005). Transcriptomic analysis of F344 rat nasal epithelium suggests that the lack of carcinogenic response to glutaraldehyde is due to its greater toxicity compared to formaldehyde. Toxicologic Pathology, 33 (4 415 424.
47. McGregor, D., Bolt, H., Cogliano, V., & Richter-Reichhelm, H. B. (2006). Formaldehyde and glutaraldehyde and nasal cytotoxicity: Case study within the context of the 2006 IPCS human framework for the analysis of a cancer mode of action for humans. Critical Reviews in Toxicology, 36 (10 821 835.
48. Sielken, R. L., Jr., Reitz, R. H., & Hays, S. M. (1996). Using PBPK modeling and comprehensive realism methodology for the quantitative cancer risk assessment of butadiene. In Proceedings of the International Symposium on the Evaluation of Butadiene & Isoprene Health Risks, June 27-29, 1995, Toxicology, 113, 231 237.
49. Clewell, H. J., III., Gentry, P. R., Covington, T. R., & Gearhart, J. M. (2000). Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environmental Health Perspectives, 108 (Suppl. 2 283 305.
50. Clewell, H. J., III., Andersen, M. E., & Barton, H. A. (2002). A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment. Environmental Health Perspectives, 110 (1 85 93.
51. Kimbell, J. S., Subramaniam, R. P., Gross, E. A., Schlosser, P. M., & Morgan, K. T. (2001). Dosimetry modeling of inhaled formaldehyde: Comparisons of local flux predictions in the rat, monkey, and human nasal passages. Toxicological Sciences, 64, 100 110.
52. Krishnan, K., & Johanson, G. (2005). Physiologically-based pharmacokinetic and toxicokinetic models in cancer risk assessment. Journal of Environmental Science and Health, Part C: Environmental Carcinogenesis and Ecotoxicology Reviews, 23 (1 31 53.
53. Chiu, W. A., Barton, H. A., DeWoskin, R. S., Schlosser, P., Thompson, C. M., Sonawane, B., Lipscomb, J. C., & Krishnan, K. (2007). Evaluation of physiologically based pharmacokinetic models for use in risk assessment. Journal of Applied Toxicology, 27 (3 218 237.
54. Stern, A. H. (2005). A revised probabilistic estimate of the maternal methyl mercury intake dose corresponding to a measured cord blood mercury concentration. Environmental Health Perspectives, 113, 155 163.
55. Bernillon, P., & Bois, F. (2000). Statistical issues in toxicokinetic modeling: A Bayesian perspective. Environmental Health Perspectives, 108 (Suppl. 5 883 893.
56. Jonsson, F., & Johanson, G. (2003). The Bayesian population approach to physiological toxicokinetic-toxicodynamic models - An example using the MCSim software. Toxicological Letters, 138 (1-2 143 150.
57. Mezzetti, M., Ibrahim, J. G., Bois, F. Y., Ryan, L. M., Ngo, L., & Smith, T. J. (2003). A Bayesian compartmental model for the evaluation of 1,3-butadiene metabolism. Journal of the Royal Statistical Society Series C-Applied Statistics, 52, 291 305.
58. Duffull, S. B., Kirkpatrick, C. J., Green, B., & Holford, N. H. (2005). Analysis of population pharmcokinetic data using NONMEM and Winbugs. Journal of Biopharmaceutical Statistics, 15, 53 73.
59. Hack, C. E. (2005). Bayesian analysis of physiologically based toxicokinetic and toxicodynamic models. Toxicology, 221, 241 248.
60. Slikker, W., Andersen, M. E., Bogdanffy, M. S., Bus, J. S., Cohen, S. D., Conolly, R. B., David, R. M., Doerrer, N. G., Dorman, D. C., Gaylor, D. W., Hattis, D., Rogers, J. M., Setzer, R. W., Swenberg, J. A., & Wallace, K 2004). Dose-dependent transitions in mechanisms of toxicity: Case studies. Toxicology and Applied Pharmacology, 201 (3 226 294.
61. Kerns, W. D., Pavkov, K. L., Donofrio, D. J., Gralla, E. J., & Swenberg, J. A. (1983). Carcinogenicity of formaldehyde in rats and mice after long-term inhalation exposure. Cancer Research, 43, 4382 4392.
62. Lapin L., & Whisler W. (2002). Quantitative Decision Making with Spreadsheet Applications, 7th ed. Belmont, CA : Wadsworth (Thomson Learning).
63. Monahan, G. E. (2000). Management Decision Making: Spreadsheet Modeling, Analysis, and Application. Cambridge, UK : Cambridge University Press.
64. Savage, S. L. (2003). Decision Making with Insight. Thomson Brooks/Cole.
65. Bedford, T., & Cooke, R. (2001). Probabilistic Risk Analysis: Foundations and Methods. Cambridge, UK : Cambridge University Press.
66. Clemen, R. T., & Reilly, T. (2001). Making Hard Decisions with Decision Tools. Belmont, CA : Duxbury Press.
67. Keefer, D. L., Kirkwood, C. W., & Corner, J. L. (2004). Perspective on decision analysis applications. Decision Analysis, 1 (1 4 22.
68. Pearl, J. (2000). Causality: Models, Reasoning, and Inference. Cambridge, UK : Cambridge University Press.
69. Jensen, F. V. (2001). Bayesian Networks and Decision Graphs. New York : Springer Verlag.
70. Biedermann, A., & Taroni, F. (2006). Bayesian networks and probabilistic reasoning about scientific evidence when there is a lack of data. Forensic Science International, 157 (2-3 163 167.
71. Taylor, A. C., Evans, J., & McKone, T. (1993). The value of animal test information in environmental control decisions. Risk Analysis, 13 (4 403 412.
72. Morgan, M. G., & Henrion, M. (1990). Uncertainty: A Guide to Dealing with Uncertainty in Quantitative Risk and Policy Analysis. Cambridge, UK : Cambridge University Press.
73. Yokota, F., & Thompson, K. M. (2004). Value of information analysis in environmental health risk management decisions: Past, present, and future. Risk Analysis, 24 (3 635 650.
74. Hammitt, J. K. (1995). Can more information increase uncertainty? Chance, 8 (3 15 17.
75. Hammitt, J. K., & Shlyakhter, A. I. (1999). The expected value of information the probability of surprise. Risk Analysis, 19 (1 135 152.
76. Small, M. J. (2004). The value of information for conflict resolution. In I. Linkov & A. Bakr Ramadan (Eds. Comparative Risk Assessment and Environmental Decision Making (pp. 171 194). Dordrecht, Netherlands : Kluwer Academic.
77. Brusick, D. (2008). Critical assessment of the genetic toxicity of naphthalene. Regulatory Toxicology and Pharmacology, 51 (2 37 42.
78. Brusick, D., Small, M. J., Cavalieri, E. L., Chakravarti, D., Ding, X., Longfellow, D. G., Nakamura, J., Rogan, E. C., & Swenberg, J. A. (2008). Possible genotoxic modes of action for naphthalene. Regulatory Toxicology and Pharmacology, 51 (2 43 50.
79. National Toxicology Program (NTP) 1992). Toxicology and carcinogenesis studies of naphthalene (CAS NO. 91-20-3) in B6C3F1 mice (inhalation studies). NTP Technical Report No. 410. Research Triangle Park, NC.
80. National Toxicology Program (NTP) 2000). Toxicology and Carcinogenesis Studies of Naphthalene (CAS no. 91-20-3) in F344/N Rats (Inhalation Studies). NTP Technical Report No. 500; National Institutes of Health Publication No. 01-4434. Research Triangle Park, NC.
81. Morgan, M. G., & Keith, D. (1995). Subjective judgments by climate experts. Environmental Science & Technology, 29 (10 468 476.
82. Stiber, N. A., Small, M. J., & Pantazidou, M. (2004). Site-specific updating and aggregation of Bayesian belief network models for multiple experts. Risk Analysis, 24 (6 1529 1538.
83. Van Der Fels-Klerx, I. H. J., Goossens, L. H. J., Saatkamp, H. W., & Horst, S. H. S. (2002). Elicitation of quantitative data from a heterogeneous expert panel: Formal process and application in animal health. Risk Analysis, 22 (1 67 81.
84. Clemen, R. T., & Winkler, R. L. (1999). Combining probability distributions from experts in risk analysis. Risk Analysis, 19 (2 187 203.
85. Van Der Fels-Klerx, I. H. J., Cooke, R. M., Nauta, M. N., Goossens, L. H., & Havelaar, A. H. (2005). A structured expert judgment study for a model of campylobacter transmission during broiler-chicken processing. Risk Analysis, 25 (1 109 124.
86. Versar, Inc. (2000). Characterization of Data Uncertainty and Variability in IRIS Assessments, Pre-Pilot vs. Pilot/ Post-Pilot. Report prepared for U.S. EPA Office of Research and Development, National Center for Environmental Assessment, Contract No. 68-C-99-238, Washington, DC. Available at http://oaspub.epa.gov/eims/eimscomm.getfile?p_download_id=4538.
87. Rinsky, R. A., Young, R. J., & Smith, A. B. (1981). Leukemia in benzene workers. American Journal of Industrial Medicine, 2, 217 245.
88. Rinsky, R. A., Smith, A. B., Horning, R., Filloon, T. G., Young, R. J., Okun, A. H., & Landrigan, P. J. (1987). Benzene and leukemia: An epidemiologic risk assessment. New England Journal of Medicine, 316, 1044 1050.
89. Crump, K. S., & Allen, B. C. (1984). Quantitative Estimates of Risk of Leukemia from Occupational Exposure to Benzene. Prepared for the Occupational Safety and Health Administration by Science Research Systems, Inc., Ruston, LA.
90. Paustenbach, D., Bass, R., & Price, P. (1993). Benzene toxicity and risk assessment, 1972-1992: Implications for future regulation. Environmental Health Perspectives, 101 (Suppl. 6 177 200.